Associations between Adipokines and Metabolic Dysfunction-Associated Fatty Liver Disease Using Three Different Diagnostic Criteria
Background: A panel of experts proposed a new definition of metabolic dysfunction-associated fatty liver disease (MAFLD) in 2020. To date, the associations between adipokines, such as adiponectin, adipsin, and visfatin and MAFLD remain unclear. Therefore, we aimed to evaluate the associations betwee...
Main Authors: | Jie Pan, Yijie Ding, Yan Sun, Qiuyan Li, Tianyi Wei, Yingying Gu, Yujia Zhou, Nengzhi Pang, Lei Pei, Sixi Ma, Mengqi Gao, Ying Xiao, De Hu, Feilong Wu, Lili Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/6/2126 |
Similar Items
-
The role of adipokines in the disease of metabolic-associated fatty liver disease
by: Chieh Chen
Published: (2023-01-01) -
Relationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease
by: Abdulrahman Ismaiel, et al.
Published: (2021-11-01) -
Maternal Blood Adipokines and Their Association with Fetal Growth: A Meta-Analysis of the Current Literature
by: Ioakeim Sapantzoglou, et al.
Published: (2024-03-01) -
Updated Clinical Evidence on the Role of Adipokines and Breast Cancer: A Review
by: Georgios-Ioannis Verras, et al.
Published: (2023-03-01) -
Pathogenesis of obesity-associated cardiovascular diseases: Key role of biomolecules
by: Shreya Sood, et al.
Published: (2023-06-01)